Industry

Enforces patents representing critical components of its broad intellectual property portfolio and reflecting key investments and innovations in clear aligner therapy, including multilayer aligner material, cutting-edge treatment planning, and advanced aligner features SAN JOSE, Calif. & TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells … [Read more…]

Former apree health CEO, Cerner President will Lead Next Phase of Company Growth CHICAGO–(BUSINESS WIRE)–Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that its Board of Directors has appointed Don Trigg, an industry leader with over two decades of healthcare technology experience, as the Company’s new Chief Executive Officer … [Read more…]

AWARD ANNOUNCEMENT: One Mind Grants $1.5M to Rising Star Mental Health Researchers at One Mind Music Festival RUTHERFORD, Calif.–(BUSINESS WIRE)–The 31st One Mind Music Festival on September 13, 2025 will be hosted at Staglin Family Vineyard in Rutherford, CA. The day-long festival, presented by Bank of America and Bristol Myers Squibb, offers a unique blend … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–MedImpact Holdings Inc. today announced that it will have access to an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than the reference Stelara® (ustekinumab). The biosimilar, distributed by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., will be available for direct purchase from MedImpact’s preferred partner, Birdi, Inc., by any licensed specialty … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced the appointment of Michael Myshrall as chief financial officer (CFO). Myshrall brings over two decades of financial leadership experience in SaaS, artificial intelligence (AI) and technology sectors, positioning him to help … [Read more…]

Financing supports execution of early-stage clinical trials for Anocca’s lead programme VIDAR-1, powered by the Company’s leading-edge R&D platform, to target pancreatic cancer VIDAR-1 is the first non-viral gene-edited TCR-T cell therapy in Europe with recruitment open SÖDERTÄLJE, Sweden–(BUSINESS WIRE)–Anocca AB (‘Anocca’ or the ‘Company’), a leading clinical-stage T-cell immunotherapy company, has successfully raised SEK … [Read more…]

GREENBRAE, Calif.–(BUSINESS WIRE)–#Marin—MarinHealth is proud to announce the naming of the Bruce Braden Progressive & Metabolic Care Unit in recognition of a generous gift from philanthropist and longtime MarinHealth supporter Bruce Braden. His ongoing commitment to advancing access to exceptional diabetes and metabolic care has made a lasting impact on the lives of patients and … [Read more…]

One-Hour Event to Air Friday, August 15 Across All iHeartRadio Country Stations and The iHeartRadio App NEW YORK–(BUSINESS WIRE)–iHeartMedia is joining forces with Stand Up To Cancer® (SU2C) for the organization’s ninth biennial one-hour, commercial-free special airing Friday, August 15, at 8 p.m. ET and PT / 7 p.m. CT. The live event will be … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. active pharmaceutical ingredients CDMO market was valued at USD 25.28 billion in … [Read more…]

Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http://proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth’s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory … [Read more…]